NovoLog Mix 70/30

Product NDC: 50090-2273
Requested package NDC: 50090-2273-0
11-digit product format: 500902273
Labeler code: 50090
Product ID: 50090-2273_54eed39e-7aff-446e-b6ea-475d77c9207c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: insulin aspart
Dosage form: INJECTION, SUSPENSION
Route: SUBCUTANEOUS
Labeler: A-S Medication Solutions
Application: BLA021172
Marketing category: BLA
Marketing start: 2001-11-01
Marketing end: 0000-00-00
Substance: INSULIN ASPART
Active strength: 100 [iU]/mL
Pharmacologic classes: Insulin [CS],Insulin Analog [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50090-2273	50090-2273-0	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
24eab60a-55c8-40c1-8c86-7ed01a7a8bef	Product name	1	20240227
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
09fb02dd-baf0-4f67-b464-599bf26324b6	Product name	2	20200323
6a6ef80c-37d6-4e02-aa78-fce7b811234e	Product name	2	20200323
91ae268d-ee0f-6988-629d-5065a4376a50	Product name	2	20200323
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-2273-0	2023-02-07	C162847	48780-1	f386c64a-3c77-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001
50090-2273-0	2023-01-30	C162847	48780-1	f386c64a-3c77-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-2273-0	NOVOLOG MIX 70/30	10 mL in 1 VIAL, GLASS	INJECTION, SUSPENSION	10		32
50090-2273-0	NOVOLOG MIX 70/30	1 in 1 CARTON	INJECTION, SUSPENSION	1		32

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-2273-0	ML - Milliliter	50090-2273	3c915b59-0ffa-4bfa-9b04-eaeeb91233df	1	2019-02-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NovoLog Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	66da64f7-ca50-47d2-95fa-de37005eef85	2026-05-18	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	REMEDYREPACK INC.	5d9f0e10-edb9-4960-bd62-cf406e75bbe7	2026-04-07	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	A-S Medication Solutions	19888a44-b330-462a-864d-338c5893dd63	2026-01-29	Warnings, Adverse reactions	Exact identifier application number: BLA021172 ndc (package): 50090-2273-0 ndc (product): 50090-2273 ndc11 (package): 50090227300
.Insulin Aspart Protamine and Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	14499781-b90e-47d5-a7de-006965439b94	2024-02-22	Warnings, Adverse reactions	Exact identifier application number: BLA021172
Insulin Aspart Protamine and Insulin Aspart Mix 70/30	INSULIN ASPART	Novo Nordisk Pharma, Inc.	fc94baa4-3606-48bc-a781-9617ab6960ef	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172
NovoLog Mix 70/30	INSULIN ASPART	Novo Nordisk	1861fcee-7673-4afe-a206-08fa05c0add2	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA021172

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
021172	Novolog Mix 70/30	insulin aspart protamine and insulin aspart	351(a)	Rx	2026-07-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D933668QVX	INSULIN ASPART	116094-23-6	INSULIN ASPART

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
847191	insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector	PSN	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin aspart protamine / insulin aspart 70/30 Injectable Suspension	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977840	NovoLOG Mix 70/30 in 3 ML Pen Injector	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977842	NovoLOG Mix 70/30 Injectable Suspension	PSN	19888a44-b330-462a-864d-338c5893dd63	32
977840	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix]	SBD	19888a44-b330-462a-864d-338c5893dd63	32
977842	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension [NovoLog Mix]	SBD	19888a44-b330-462a-864d-338c5893dd63	32
847191	3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector	SCD	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable Suspension	SCD	19888a44-b330-462a-864d-338c5893dd63	32
351297	insulin analog, aspart mixed 70/30 100 UNT/ML Injectable Suspension	SY	19888a44-b330-462a-864d-338c5893dd63	32
847191	insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector	SY	19888a44-b330-462a-864d-338c5893dd63	32
977842	NovoLog Mix 70/30 Injectable Suspension	SY	19888a44-b330-462a-864d-338c5893dd63	32
977840	NovoLog Mix 70/30 per 3 ML Pen Injector	SY	19888a44-b330-462a-864d-338c5893dd63	32

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-2273-0	50090227300	1 VIAL, GLASS in 1 CARTON (50090-2273-0) > 10 mL in 1 VIAL, GLASS	2015-12-15	0000-00-00	No	No	Current